Welcome to LookChem.com Sign In|Join Free

CAS

  • or

352431-47-1

Post Buying Request

352431-47-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

352431-47-1 Usage

Uses

3-Methylbutyraldehyde-2,2-d2 (CAS# 352431-47-1) is a useful isotopically labeled research compound.

Check Digit Verification of cas no

The CAS Registry Mumber 352431-47-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,2,4,3 and 1 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 352431-47:
(8*3)+(7*5)+(6*2)+(5*4)+(4*3)+(3*1)+(2*4)+(1*7)=121
121 % 10 = 1
So 352431-47-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H10O/c1-5(2)3-4-6/h4-5H,3H2,1-2H3/i3D2

352431-47-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,2-dideuterio-3-methylbutanal

1.2 Other means of identification

Product number -
Other names BIM0590

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:352431-47-1 SDS

352431-47-1Downstream Products

352431-47-1Relevant articles and documents

DEUTERATED ANALOGS OF ACETYL-LEUCINE

-

Paragraph 0530; 0532, (2020/07/05)

The present disclosure provides compounds represented by Formula I: I, and the pharmaceutically acceptable salts and solvates thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 are as defined as set forth in the specification, and the deuterium enrichment of any one or more of R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and R13 is about 15% or more. The present disclosure also provides compounds having Formula I for use to treat or delay the progression of a lysosomal storage disorder or a neurodegenerative disease in a subject, provide neuroprotection in a subject having a lysosomal disorder, treat or prevent a migraine, and the symptoms associated therewith, in a subject, or improve mobility and/or cognitive function in a subject.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 352431-47-1